Observations uncover progressive graft loss due to chronic allograft ischemia in a kidney transplant infant, suggesting long-term surveillance is vital.
[SUMMARY] Kidney transplantation(KTx)in infants(body weight[BW] <10 kg and/or body surface area[BSA] <0.5 m2)is an accepted treatment option for chronic kidney disease in children and has demonstrated excellent short-term graft survival. However, follow-up studies longer than five years are still lacking. We experienced a case of an infant(BW 9.2 kg, BSA 0.44 m2)with an adult-sized kidney(ASK)transplant(donor-recipient height ratio : 2.24)which resulted in graft loss at 9.7 years after the transplant secondary to biopsy-proven chronic allograft ischemia(CAI). Intensive maintenance fluid supplementation failed to prevent ongoing and long-standing graft hypoperfusion. While the decrease in the estimated glomerular filtration rate(eGFR)was irregular, the progression of chronic changes seen in the graft biopsies was linear, both in early- and late-phase KTx. CAI in significantly size-mismatched ASKs transplanted into infants can promote late graft failure within ten years. Since serial evaluations of renal histology were shown to be a better indicator of renal graft outcomes throughout the post-transplant course, transplant surveillance biopsies beyond the early phase of KTx may assist in elucidating the natural course of CAI in ASKs transplanted into infant recipients.
No takes yet. Share an insight, caveat, or question.
Yoshimura et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: